Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Equine Imaging Services Market Size & Share 2025-2035
Report ID: GMI13370
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Equine Imaging Services Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Equine Imaging Services Market Size
The equine imaging services market was valued at USD 870 million in 2024, is projected to reach USD 930 million in 2025, is expected to grow at a 6.5% CAGR (2026–2035), and is forecast to reach USD 1.76 billion by 2035. The market covers demand-side revenue from imaging equipment, software, service contracts, and related diagnostic solutions used exclusively in equine health management.
Equine Imaging Services Market Key Takeaways
Market Leader: Hallmarq Veterinary Imaging led with over 13% market share in 2024.
Leading Players: Top 5 players in this market include Hallmarq Veterinary Imaging, Fujifilm Corporation, BCF Technology, IDEXX Laboratories, Canon Medical Systems, which collectively held a market share of 40% in 2024.
The equine imaging services market is moving from a referral-center-led diagnostic model toward a more distributed service architecture. Competitive sport, higher owner expectations for earlier diagnosis, and safer standing-patient technologies are expanding the clinical role of imaging while preserving a premium for specialist interpretation and multi-modality capability.
GMI Analyst View
Based on input from industry leaders, the equine imaging services market generated USD 760 million in 2022, establishing the compounding growth trajectory that accelerated through the historic period and positions demand for sustained mid-to-upper-single-digit expansion across the forecast horizon.
Equine Imaging Services Market Trends, Growth Drivers & GMI Forecast Outlook
Demand is increasingly shaped by the interaction between performance-horse care, technology that reduces anesthesia dependence, and delivery models that bring advanced diagnostics closer to farms and competition venues. Growth will favor providers that combine modality breadth, clinical workflow support, and access to qualified interpretation.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Competitive equestrian activity creates a recurring diagnostic requirement rather than a purely episodic injury market. Pre-purchase examinations, rehabilitation monitoring, welfare oversight, and competition-readiness assessments all support imaging utilization, particularly where owners, trainers, insurers, and referral clinicians operate within established performance-horse ecosystems.
Standing MRI and cone-beam CT are changing the economic case for advanced imaging by reducing the logistical burden of anesthetic-dependent examinations. The University of Edinburgh's Dick Vet Equine Hospital added a standing VisionCT scanner to complement its standing MRI capability, illustrating how referral facilities are building integrated diagnostic suites around lower-risk patient positioning and faster clinical workflow [5]University of Edinburgh (Royal (Dick) School of Veterinary Studies). "Dick Vet Equine Hospital first in Scotland to offer standing CT and MRI to patients." vet.ed.ac.uk.
AI-enabled acquisition, image-management, and interpretation support can raise consistency in decentralized settings. The commercial opportunity is not limited to software sales: better protocol adherence and smoother image transfer can make portable imaging more viable for ambulatory providers that must balance field speed, clinical confidence, and specialist review.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Advanced imaging remains economically selective because equipment amortization, specialized staffing, facility preparation, and post-scan interpretation are embedded in the service offering. This sustains a premium tier centered on insured or high-value performance horses, while routine-care populations continue to rely more heavily on radiography and ultrasonography. Mobile delivery can improve access, but it does not remove the economics of high-complexity procedures.
Workforce availability is a capacity issue as much as a labor issue. Imaging systems may be physically installed, yet their commercial utilization depends on clinicians who can acquire technically sound studies and specialists who can interpret them promptly. Tele-radiology mitigates part of this constraint, although urgent lameness and competition cases still reward providers with local clinical depth.
Regulatory requirements also influence market structure. Established vendors can distribute compliance, documentation, and post-market responsibilities across broader product portfolios, whereas smaller equine-focused entrants face proportionally higher costs when moving portable systems or software-enabled workflows into multiple jurisdictions.
GMI Analyst View
We view the central forecast tension as one between widening access and persistent clinical scarcity. Portable systems can extend the point of care, but the value of an imaging service still depends on image quality, timely interpretation, and a credible pathway from diagnosis to treatment.
Equine Imaging Services Market Segment Analysis
By Modality
The Equine Imaging Services Market continues to rely on X-ray / Digital Radiography as its broadest first-line modality, with revenue of USD 326 million in 2025 and a projected USD 500 million by 2035. Its installed-base advantage reflects portability, low preparation requirements, and broad clinician familiarity; however, its role is increasingly as the entry point to a diagnostic pathway that may escalate to MRI or CT when radiographic findings do not explain clinical signs.
Ultrasonography represented 28.0% of market revenue in 2025 and is projected to generate USD 460 million by 2035. Its non-ionizing, portable format aligns closely with ambulatory work for tendons, ligaments, soft tissue, and reproductive examination. Wireless platforms and improved image-management workflows strengthen its field relevance, although operator technique remains a meaningful determinant of diagnostic consistency.
MRI, including standing and recumbent systems, is projected to account for 23.0% of modality revenue by 2035 and expand at a 9.8% CAGR (2025–2035). The modality's appeal is rooted in detailed soft-tissue and distal-limb visualization, particularly where radiography lacks sufficient contrast resolution. Standing configurations have widened the addressable clinical population by reducing dependence on general anesthesia, supporting adoption at specialist facilities and advanced mobile platforms.
Computed Tomography (CT) is forecast to reach USD 274 million by 2035, rising from a 12.0% share of modality revenue in 2025. Three-dimensional imaging supports complex orthopedic, dental, and sinus assessments where structural anatomy must be visualized beyond planar radiography. CT demand is especially sensitive to facility infrastructure, referral patterns, and the ability to offer patient positioning approaches that lower procedural friction.
Nuclear Scintigraphy generated USD 46 million in 2025 and is forecast to reach USD 88 million by 2035. Its specialized role in identifying stress injury and occult skeletal pathology preserves its relevance in high-performance horse populations, but radiopharmaceutical handling, capital intensity, and clinical workflow requirements confine deployment largely to academic and high-capability referral settings.
Other Modalities are projected to account for 1.9% of modality revenue by 2035, compared with 3.0% in 2025. Thermography and emerging PET applications may retain clinical value in selected pathways, yet their commercial contribution will remain limited until reimbursement, protocol standardization, and infrastructure barriers are addressed more broadly.
By Application
Musculoskeletal / Orthopedic applications generated USD 539 million in 2025 and are projected to reach USD 1.02 billion by 2035. Lameness evaluation remains the dominant imaging trigger in performance-horse care, driving demand for staged workups that begin with accessible modalities and progress to MRI or CT when clinicians require more definitive evidence of joint, tendon, ligament, or osseous injury.
Soft Tissue applications accounted for 21.0% of application revenue in 2035 and generated USD 195 million in 2025. Portable ultrasonography supports routine field assessment, while MRI provides additional value for complex tendon and ligament pathology. The segment's durability reflects repeat monitoring needs in racehorses and sport horses, where treatment decisions often depend on changes in tissue appearance over time.
Dental & Sinus applications represented 10.0% of revenue in 2025 and are projected to generate USD 176 million by 2035. CT is becoming more influential in these cases because equine cranial anatomy can obscure pathology on conventional views. Referral providers that establish dedicated skull-imaging protocols can differentiate on diagnostic confidence, surgical planning support, and case turnaround.
Respiratory / Thoracic applications are projected to generate USD 123 million by 2035, after representing 7.0% of application revenue in 2025. Ultrasonography and radiography remain practical tools for acute respiratory presentations, while software-supported image review may increase diagnostic consistency. Adoption will depend on whether equine clinicians integrate imaging earlier in respiratory decision pathways rather than reserving it for complicated cases.
Other Applications are expected to account for 4.0% of application revenue by 2035 and generated USD 37 million in 2025. Neurological, ophthalmic, and oncological use cases remain clinically important but comparatively concentrated within academic institutions and advanced referral hospitals. Their market contribution will depend on the commercialization of specialized workflows rather than on broad-based routine adoption.
By End Use
Equine Hospitals & Referral Centers generated USD 502 million in 2025 and are expected to grow at a 6.0% CAGR (2025–2035). These facilities remain the principal location for MRI, CT, and scintigraphy because they can support specialized staffing, patient preparation, regulatory obligations, and multi-modality case management. Their competitive advantage increasingly rests on integrating imaging with surgery, rehabilitation, and specialist consultation.
Ambulatory / Mobile Veterinary Services are projected to generate USD 700 million by 2035 and expand at an 8.3% CAGR (2025–2035). Mobile delivery is gaining relevance where horse transport is undesirable or impractical, including breeding farms, training centers, racetracks, and event venues. The channel's growth will be determined by whether providers can pair increasingly capable equipment with dependable specialist interpretation and scalable route economics.
Academic & Research Institutions accounted for 12.0% of end-user revenue in 2025 and are projected to represent 9.1% by 2035. Although their relative contribution is expected to moderate as private referral capacity expands, these institutions remain important first-installation and validation sites for novel imaging modalities. Their influence extends beyond direct revenue through clinician training, protocol development, and evidence generation.
GMI Analyst View
We expect the most consequential segment shift to arise from the interaction of advanced modalities with mobile delivery, not from the displacement of basic imaging. Providers able to move sophisticated diagnostic capability closer to horses without compromising clinical confidence will challenge the traditional boundary between field practice and referral care.
Equine Imaging Services Market Regional Analysis
North America Equine Imaging Services Market Analysis
The Equine Imaging Services Market in North America generated USD 326 million in 2025 and is projected to reach USD 572 million by 2035. Dense performance-horse populations, established referral networks, and insurance-supported diagnostics provide a favorable environment for advanced modality adoption. The region also benefits from a comparatively mature specialist workforce, although interpretation capacity remains uneven outside major equine centers.
U.S.
The U.S. generated USD 287 million in 2025 and is forecast to grow at a 5.7% CAGR (2025–2035). Premier referral hospitals, university affiliations, and concentrated racing activity support demand for standing MRI, scintigraphy, and advanced lameness workups. Welfare expectations and pre-race diagnostic practices reinforce utilization in key racing states.
Canada
Canada represented 12.0% of North American revenue in 2025 and is expected to grow at a 6.6% CAGR (2025–2035). Mobile imaging services are particularly relevant in a geographically dispersed market where transporting horses to specialist facilities can be costly and disruptive. Broader field access should support incremental demand beyond core equine concentrations in Ontario and Alberta.
Europe Equine Imaging Services Market Analysis
Europe generated USD 279 million in 2025 and is projected to expand at a 6.0% CAGR (2025–2035). The region combines a dense referral-hospital base with established racing, showjumping, dressage, and eventing ecosystems. Regulatory compliance can slow market entry for smaller vendors, but it also reinforces the position of suppliers able to support documentation, service, and multi-country deployment.
U.K.
The U.K. generated USD 70 million in 2025 and is projected to reach USD 122 million by 2035. Thoroughbred racing, specialist referral infrastructure, and domestic standing-MRI expertise create a sophisticated demand base. The country's leading veterinary hospitals also influence procurement and clinical protocols in adjacent European markets.
Germany
Germany generated USD 61 million in 2025 and is forecast to grow at a 6.3% CAGR (2025–2035). Its Warmblood breeding and competition ecosystem supports consistent demand for pre-purchase examination, orthopedic assessment, and performance monitoring. Advanced imaging is increasingly part of routine risk management for high-value sport-horse transactions.
France
France represented 17.9% of European revenue in 2025 and is projected to generate USD 90 million by 2035. Strong competition-horse activity and investments in specialist diagnostic infrastructure support adoption. Multi-site referral models can improve equipment utilization by concentrating technical expertise while extending commercial reach across geographically dispersed client bases.
Netherlands
The Netherlands generated USD 25 million in 2025 and is projected to reach USD 46 million by 2035. A concentrated breeding and showjumping economy supports early adoption of advanced imaging, while cross-border links with neighboring equine markets broaden the addressable referral base. Providers that combine diagnostic specialization with efficient scheduling are well positioned in this high-density clinical environment.
Asia Pacific Equine Imaging Services Market Analysis
Asia Pacific generated USD 205 million in 2025 and is projected to reach USD 440 million by 2035. The region combines mature racing markets with developing equestrian infrastructure, creating diverse modality requirements. Australia and Japan provide established clinical demand, while China and India offer longer-term opportunity as specialist facilities, training capacity, and owner spending develop.
Australia
Australia generated USD 72 million in 2025 and is forecast to grow at an 8.0% CAGR (2025–2035). Its concentrated Thoroughbred industry and accessible breeding corridors create favorable route density for mobile providers. Referral hospitals can use standing and portable advanced imaging to serve both high-value racing clients and regional veterinary networks.
Japan
Japan accounted for 24.9% of Asia Pacific revenue in 2025 and is projected to generate USD 101 million by 2035. Formal racing systems and concentrated licensed horse populations sustain advanced musculoskeletal imaging demand. The market's technical sophistication favors providers capable of supporting integrated, multi-modality clinical workflows.
China
China generated USD 41 million in 2025 and is expected to account for 22.0% of Asia Pacific revenue by 2035. Growth is linked to the gradual formalization of equestrian clubs, competition infrastructure, and specialist veterinary services in major urban centers. Demand will advance from foundational radiography toward higher-complexity modalities as referral pathways and clinician expertise deepen.
India
India represented 9.8% of Asia Pacific revenue in 2025 and is forecast to grow at an 8.7% CAGR (2025–2035). Racing centers and institutional investments provide the initial commercial base, while the wider opportunity depends on mobile service expansion and additional specialist training. The market's potential is substantial, but adoption will remain uneven between metropolitan racing hubs and rural working-equine settings.
Latin America Equine Imaging Services Market Analysis
Latin America represented 8.0% of global revenue in 2025 and is projected to generate USD 157 million by 2035. Participation in polo, racing, breeding, and showjumping supports demand, but access remains strongly tied to urban referral capacity and mobile service availability. Growth will favor vendors and service providers that can manage capital constraints while addressing dispersed horse populations.
Brazil
Brazil accounted for 51.4% of Latin American revenue in 2025 and is projected to generate USD 82 million by 2035. Large breeding operations, polo activity, and regional sporting traditions create a broad clinical base. Mobile services are strategically important for extending imaging access into interior breeding regions where fixed referral capacity remains limited.
Argentina
Argentina generated USD 15 million in 2025 and is forecast to grow at a 7.9% CAGR (2025–2035). Polo and Thoroughbred breeding provide a recurring orthopedic and soft-tissue diagnostic pipeline. Advanced modality investment is likely to cluster around premier facilities and high-value competition-horse populations before diffusing more broadly.
Mexico
Mexico represented 14.9% of Latin American revenue in 2025 and is projected to reach USD 23 million by 2035. Formalization of equestrian venues and investments in veterinary capability are expanding the clinical use of imaging. The market's development will depend on whether specialist access grows alongside equipment deployment.
Middle East & Africa Equine Imaging Services Market Analysis
Middle East & Africa generated USD 47 million in 2025 and is projected to grow at a 6.5% CAGR (2025–2035). Premium racing, endurance, and Arabian-horse ecosystems underpin demand in Gulf markets, while specialist availability and equipment import costs constrain broader regional diffusion. High-value facilities continue to anchor adoption of advanced modalities.
UAE
The UAE generated USD 14 million in 2025 and is projected to reach USD 27 million by 2035. International racing and endurance activity supports specialized imaging at premium equine hospitals, particularly where high-value horses require rapid diagnostic assessment. The market benefits from demand that is concentrated, well funded, and internationally connected.
Saudi Arabia
Saudi Arabia accounted for 23.4% of Middle East & Africa revenue in 2025 and is forecast to grow at a 7.2% CAGR (2025–2035). Expanding equestrian infrastructure is increasing the need for diagnostic capability that supports elite competition and breeding programs. The country presents a meaningful growth opportunity for suppliers that can meet local service, training, and regulatory needs.
South Africa
South Africa generated USD 8 million in 2025 and is projected to reach USD 14 million by 2035. Thoroughbred racing provides the core demand base, with radiography and ultrasonography continuing to dominate everyday practice. Advanced imaging will remain concentrated in major centers until specialist availability and capital-access constraints ease.
GMI Analyst View
We see Asia Pacific and Latin America as important expansion territories for different reasons. Asia Pacific is increasingly technology-led, whereas Latin America is more participation-led; this distinction will influence the pace of advanced-modality adoption, the attractiveness of mobile models, and the suppliers best positioned to build local share.
Equine Imaging Services Market Share & Competitive Landscape
The Equine Imaging Services Market share landscape is moderately fragmented, with the top five suppliers collectively accounting for approximately 40% of global revenue in 2025. Competition is shaped by modality specialization, installed-base density, clinical support, distribution reach, and the ability to integrate equipment with image management and service contracts. No single participant combines universal strength across advanced equine imaging, field diagnostics, and referral services.
Hallmarq Veterinary Imaging held a 13% share in 2025. Its equine-focused standing MRI and CT portfolio gives the company a differentiated position in advanced imaging, particularly where providers want to reduce reliance on general anesthesia. The company's installed-base model and clinical support infrastructure can reinforce recurring relationships with referral hospitals and academic sites.
Fujifilm Corporation held a 9% share in 2025. Its position is supported by digital radiography and veterinary distribution capabilities, especially in applications where durable portable systems and dependable workflow integration are more important than highly specialized advanced-modality capability. This breadth supports engagement with both referral facilities and ambulatory practices.
BCF Technology held a 7% share in 2025. Its focus on portable ultrasonography and radiography aligns with the needs of ambulatory veterinarians seeking practical equipment with manageable capital requirements. The company is particularly exposed to the growth of field-based diagnostic workflows and mobile equine care.
IDEXX Laboratories participates through practice-management, diagnostics, and clinical data integration, rather than through a narrowly equine-specific imaging portfolio. Its strategic relevance lies in connecting imaging records with broader veterinary workflows, which can improve operational stickiness for practices that use integrated information systems.
Canon Medical Systems is positioned primarily in high-capital CT and radiography applications adapted from broader medical-imaging capabilities. Its opportunity is concentrated in referral environments where sophisticated imaging performance, service reliability, and institutional procurement processes carry more weight than portability.
IMV Imaging, VET.CT, and regional specialist providers such as Hagyard Equine Medical Institute, Mid-Atlantic Equine Medical Center, Virginia Equine Imaging, Tennessee Equine Hospital, Rainbow Equine Hospital, and the Royal Veterinary College's Equine Referral Hospital compete through clinical access, referral relationships, interpretation expertise, and local service delivery. Emerging operators, including Daniel Equine Services and Vets Pets, illustrate the market's continuing shift toward more accessible ambulatory and mixed-practice imaging models.
Recent Industry Developments
In September 2025, IMV Imaging and Asto CT announced a strategic partnership combining IMV Imaging's veterinary distribution reach with Asto CT's Equina® weight-bearing fan-beam CT platform. The partnership is intended to broaden commercial access to standing CT technology for equine and mixed-practice veterinary settings [6]Asto CT. "IMV Imaging and Asto CT Forge Strategic Partnership to Advance Veterinary Diagnostic Imaging." astoct.com.
In December 2025, Hallmarq Veterinary Imaging and Patterson Veterinary announced a distribution partnership for Hallmarq's advanced imaging systems in North America. The arrangement expands Hallmarq's access to capital-equipment sales channels and may support wider adoption of standing MRI among practices that have historically referred complex imaging cases externally [7]Hallmarq Veterinary Imaging. "Hallmarq + Patterson: expanding access to advanced veterinary imaging." hallmarq.net.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →